Logo-bi
Review
Sepideh Parvizpour, Jafar Razmara, Yadollah Omidi* ORCID
Bioimpacts. 2018;8(3): 223-235. doi: 10.15171/bi.2018.25
PMCID: PMC6128970     PMID: 30211082     Scopus ID: 85050689925    
Original Research
Sepideh Parvizpour, Jafar Razmara, Mohammad M. Pourseif, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(1): 45-56. doi: 10.15171/bi.2019.06
PMCID: PMC6378095     PMID: 30788259     Scopus ID: 85060470196    
Using immunoinformatic tools, a multi-epitope peptide vaccine (consisting of CD8+cytotoxic T lymphocytes epitopes, helper epitopes and adjuvant) was designed to combat the triple-negative breast cancer. The vaccine showed acceptable immunogenicity and potential to stimulate both cellular and humoral immune responses.
Original Research
Elaheh Dalir Abdolahinia, Behzad Jafari, Sepideh Parvizpour, Jaleh Barar ORCID, Samad Nadri*, Yadollah Omidi* ORCID
BioImpacts. 2021;11(2): 111-117. doi: 10.34172/bi.2021.18
PMCID: PMC8022235     PMID: 33842281     Scopus ID: 85106569770    
Based on in vitro and in silico findings, MC is suggested as an important ECMmimicking entity that can support the semi-solid medium and promote the formation of the uniform spheroid in the 3D culture.
Original Research COVID-19
Mohammad Mostafa Pourseif ORCID, Sepideh Parvizpour, Behzad Jafari, Jaber Dehghani ORCID, Behrouz Naghili, Yadollah Omidi* ORCID
BioImpacts. 2021;11(1): 65-84. doi: 10.34172/bi.2021.11
PMCID: PMC7803919     PMID: 33469510     Scopus ID: 85099197264    
Immunodominant T-cell epitopes of SARS-CoV-2 spike protein with the highest population coverage were predicted by analyzing peptide binders and consensus rank (CR) score. Multi-method B-cell epitope prediction approach was used to find B-cell immunodominant regions of spike protein. Upon the high immune-potent regions of the antigen(s), self-amplifying mRNA and peptide-based vaccines were designed.

Review
Sepideh Parvizpour* ORCID, Hanieh Beyrampour-Basmenj, Jafar Razmara* ORCID, Farhad Farhadi, Mohd Shahir Shamsir
Bioimpacts. 2024;. doi: 10.34172/bi.2023.29957
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge